The R&D team has developed modified-release formulations to improve therapeutic performance, stability, and patient compliance, while introducing easy-to-swallow, patient-friendly dosage forms.
The R&D team has introduced patient-centric innovations such as modified-release and fixed-dose combinations, improved taste masking and coatings, and easy-to-administer tablets, enhancing acceptance and adherence, especially for paediatric and geriatric patients.
The organization uses a structured lifecycle approach to ensure quality, compliance, and supply reliability through continuous improvement and effective change management.
Company Identification Number
( CIN ) : U24230MH1975PLC018296
Medley House, D2,
M.I.D.C. Area,
Andheri (East),
Mumbai-400 093, INDIA